Literature DB >> 16492159

Peptide-based molecules in angiogenesis.

Luca Domenico D'Andrea1, Annarita Del Gatto, Carlo Pedone, Ettore Benedetti.   

Abstract

Angiogenesis refers to the process of remodeling the vascular tissue characterized by the branching out of a new blood vessel from a pre-existing vessel. Angiogenesis is particularly active during embryogenesis, while during adult life it is quiescent and limited to particular physiologic phenomena. Recently, the study of molecular mechanisms of angiogenesis has stirred renewed interest due to the recognition of the role played by angiogenesis in several pathologies of significant medical impact, such as cancer and cardiovascular disease, and due to the pharmacologic interest rising from the possibility of modulating these phenomena. Antibodies, peptides and small molecules targeting active endothelial cells represent an innovative tool in therapeutic and diagnostic fields. In this study, we reviewed the literature of peptide and peptidomimetics in angiogenesis and their potential applications. Two specific protein systems, namely the vascular endothelial growth factor and its receptor and integrins, will be discussed in detail.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16492159     DOI: 10.1111/j.1747-0285.2006.00356.x

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  27 in total

1.  Differential effects of a soluble or immobilized VEGFR-binding peptide.

Authors:  Justin T Koepsel; Eric H Nguyen; William L Murphy
Journal:  Integr Biol (Camb)       Date:  2012-06-25       Impact factor: 2.192

2.  Improving tumor uptake and excretion kinetics of 99mTc-labeled cyclic arginine-glycine-aspartic (RGD) dimers with triglycine linkers.

Authors:  Jiyun Shi; Lijun Wang; Young-Seung Kim; Shizhen Zhai; Zhaofei Liu; Xiaoyuan Chen; Shuang Liu
Journal:  J Med Chem       Date:  2008-12-25       Impact factor: 7.446

3.  Smart Polymeric Gels: Redefining the Limits of Biomedical Devices.

Authors:  Somali Chaterji; Il Keun Kwon; Kinam Park
Journal:  Prog Polym Sci       Date:  2007-08       Impact factor: 29.190

4.  Supramolecular nanostructures that mimic VEGF as a strategy for ischemic tissue repair.

Authors:  Matthew J Webber; Jörn Tongers; Christina J Newcomb; Katja-Theres Marquardt; Johann Bauersachs; Douglas W Losordo; Samuel I Stupp
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-01       Impact factor: 11.205

5.  The role of poly(ethylene glycol) brush architecture in complement activation on targeted microbubble surfaces.

Authors:  Cherry C Chen; Mark A Borden
Journal:  Biomaterials       Date:  2011-06-17       Impact factor: 12.479

6.  2-Mercaptoacetylglycylglycyl (MAG2) as a bifunctional chelator for 99mTc-labeling of cyclic RGD dimers: effect of technetium chelate on tumor uptake and pharmacokinetics.

Authors:  Jiyun Shi; Young-Seung Kim; Sudipta Chakraborty; Bing Jia; Fan Wang; Shuang Liu
Journal:  Bioconjug Chem       Date:  2009-07-15       Impact factor: 4.774

Review 7.  Radiolabeled cyclic RGD peptides as integrin alpha(v)beta(3)-targeted radiotracers: maximizing binding affinity via bivalency.

Authors:  Shuang Liu
Journal:  Bioconjug Chem       Date:  2009-12       Impact factor: 4.774

8.  Differential regulation of angiogenesis using degradable VEGF-binding microspheres.

Authors:  David G Belair; Michael J Miller; Shoujian Wang; Soesiawati R Darjatmoko; Bernard Y K Binder; Nader Sheibani; William L Murphy
Journal:  Biomaterials       Date:  2016-03-16       Impact factor: 12.479

9.  (99m)Tc-Galacto-RGD2: a novel 99mTc-labeled cyclic RGD peptide dimer useful for tumor imaging.

Authors:  Shundong Ji; Andrzej Czerwinski; Yang Zhou; Guoqiang Shao; Francisco Valenzuela; Paweł Sowiński; Satendra Chauhan; Michael Pennington; Shuang Liu
Journal:  Mol Pharm       Date:  2013-08-06       Impact factor: 4.939

Review 10.  Cooperation between integrin alphavbeta3 and VEGFR2 in angiogenesis.

Authors:  Payaningal R Somanath; Nikolay L Malinin; Tatiana V Byzova
Journal:  Angiogenesis       Date:  2009-03-08       Impact factor: 9.596

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.